Most Popular Stories
- Community Health Systems (CYH) Q3 Results - Q3 Top Hospital Chains Earnings Report
- CDC: H1N1 cases down in some parts of U.S.
- Tenet Healthcare (THC) Q3 Results - Q3 Top Hospital Chains Earnings Report
- Initial 'meaningful use' standards to be simple, as deadline is in sight
- Disparity researchers still stumped on colon cancer outcome differences
- Conservatives on Hill say individual mandate is unconstitutional
Featured Jobs
-
Psychiatric Job in Arkansas
StaffPointe, LLC - Little Rock, AR -
Internal Medicine Job for Indiana
StaffPointe, LLC - north, IN -
RN Manager of Inpatient Rehab
MRI of St Petersburg - St. Petersburg, FL -
Urgent Care Physician Job in Indiana
StaffPointe, LLC - Indianapolis, IN -
Director of Rehabilitation Job in Florida
StaffPointe, LLC - north, FL
Events
- Harvard Business School 7th Healthcare Conference
January 30, 2010 - Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- health reform
- prescription drugs
- pharmaceutical companies
ME judge nixes law limiting prescribing data access
It looks like the prescription data miners have won another victory. After successfully challenging a similar law in New Hampshire, Wolters Kluwer Health, IMS Health and Verispan have won an action blocking the state of Maine from enforcing a law limiting their access to physician prescribing information. Companies like these gather data on physician prescribing patterns, then sell it to pharmas, who use it tailoring their physician marketing campaigns. But several states, including Maine and New Hampshire, have considered or implemented laws restricting this practice.
In enacting such laws, legislators have argued that prescription data-mining and sales can lead to pharmas having undue influence over physicians, and ultimately, to increased healthcare costs due to the undue use of costly new drugs. The companies, however, have argued that restricting their access to this information violated their First Amendment rights. The decision follows the April 2007 overturning of a similar (but more restrictive) law which had been enacted New Hampshire.
To find out more about the decision:
- read this Kaiser Daily Health Policy Report piece
Related Articles:
Fight continues over state limits on prescription data mining. Report
Data providers challenge prescription-privacy laws. Report
NH bans prescription data collection by pharmas. Report
Pharmas protest NH drug info law. Report
Law would make pharmas reveal MD payments. Report
Related Stories
- FTC: Pharmas cut 14 deals to delay generic sales in '07
- Grassley investigates Medicaid drug claims
- Trend: Nursing homes big users of antipsychotic meds
- FDA to further investigate anemia drug risks
- Bill would make pharmas, device makers disclose gifts
- Who will pay for DTC pharma ad oversight?
- Vytorin, Avandia raise doubt on FDA approvals
- Senators plan bill countering pharma detailing tactics
- Generics save consumers, insurers $1 billion
- Merck agrees to $58M settlement on Vioxx ads
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





